AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

AJPH First Look, published online ahead of print Jun 12, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
AJPH.2008.138776v1
98/8/1350    most recent
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Silbergeld, E. K.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Silbergeld, E. K.
Related Collections
Right arrow Other Child and Adolescent Health
Right arrow Disability
Right arrow Health Policy
Right arrow Immunization/Vaccines
Right arrow History
August 2008, Vol 98, No. 8 | American Journal of Public Health 1350
© 2008 American Public Health Association
DOI: 10.2105/AJPH.2008.138776

LETTER

MERCURY, VACCINES, AND AUTISM, REVISITED

Ellen K. Silbergeld, PhD

Ellen K. Silbergeld is with the Department of Environmental Health Sciences, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD.

Correspondence: Requests for reprints should be sent to Professor Ellen K. Silbergeld, PhD, Johns Hopkins University, Bloomberg School of Public Health, Department of Environmental Health Sciences, 615 N Wolfe St, Baltimore, MD 21205 (e-mail: esilberg@jhsph.edu).

Because this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

Baker’s recent article1 presented fascinating insights and perspectives on the intertwined stories of mercury, vaccines, and autism. As a researcher in mercury with some involvement in the autism issue (as a participant in expert committees for the National Institutes of Health, the National Research Council, and the Environmental Protection Agency [EPA] as well as an invited reviewer of a proposed clinical trial of mercury chelation in autism), I would like to offer some additions to an excellent article.

First, it is not entirely correct to suggest that there is no medical knowledge of the potential hazards associated with thimerosal apart . . . [Full Text]






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Public Health Association